CSL (ASX:CSL) share price and 2 other ASX stocks among latest broker "buy" ideas

The CSL Limited (ASX:CSL) share price may not have been a star performer in the post COVID‐19 bounce, but that could soon change.

ASX shares Hand writing Time to Buy concept clock with blue marker on transparent wipe board.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The CSL Limited (ASX:CSL) share price may not have been a star performer in the post COVID‐19 bounce, but that could soon change.

Shares in the blood products developer dipped nearly 3% since March when the pandemic rattled markets.

It's performance is roughly inline with the S&P/ASX 200 Index (Index:^AXJO), although UBS reckons it could soon outperform.

Shot in the arm for CSL share price

The catalyst is the upcoming flu season in the northern hemisphere. The broker believes this year's season will be worse than normal.

"As at 9 October, 139mn flu vaccine doses had been distributed for the US flu season, up 9% vs. pcp [previous corresponding period]," said UBS.

"CSL noted at their FY20 result they had increased supply into the US of up to ~60mn doses for the 20/21 season (up from ~50mn in pcp, i.e. +20%)."

Broker "buy" rating reaffirmed on positive outlook

It also looks like Europe and the UK are facing a colder than normal winter – perfect conditions for the flu.

The unpleasant experience from COVID-19 should also aid demand for flu jabs. People are more likely to get a shot while governments are increasing their health budgets to pay for flu and coronavirus vaccinations.

UBS reiterated its "buy" recommendation on CSL with a 12-month price target of $346 a share.

Unlocking value key to buy recommendation

The Downer EDI Limited (ASX: DOW) share price is another that could outperform in the near-term. Macquarie Group Ltd (ASX: MQG) believes a potential sale of Downer's mining division will fetch a better than expected price.

The broker's optimism is based on Cimic Group Ltd's (ASX: CIM) divestment of Thiess. The transaction ascribes the business with an enterprise value of $4.3 billion, or 8.1 times forecast pre-tax profit.

If the same multiple was applied to Downer's unwanted asset, the mining business could fetch up to $713 million. This compares to the net asset value of $599 million for the business that is recorded in Downer's FY20 accounts.

Macquarie is keeping its "outperform" recommendation on the stock with a 12-month price target of $5.29 a share.

Strong September quarter supports broker's "buy" call

Meanwhile, Citigroup repeated its "buy" recommendation on the South32 Ltd (ASX: S32) share price after the miner released its quarterly report.

South32 posted record hydrate production at Worsley Alumina. It also remains on track to increase alumina production to nameplate capacity in FY21.

Overall, Citi described the quarterly as a strong report with management sticking to its production forecasts for the current financial year.

South32 also restarted its on-market share buyback as its net cash position increased by US$70 million to US$368 million in the quarter.

Citi's 12-month price target on the stock is $2.60 a share.

Brendon Lau owns shares of CSL Ltd., Macquarie Group Limited, and South32 Ltd. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia owns shares of and has recommended Macquarie Group Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

ASX shares Business man marking buy on board and underlining it
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

Read more »

Man ponders a receipt as he looks at his laptop.
Technology Shares

Brokers rerate 3 leading ASX 200 tech stocks

Experts reveal their ratings on the ASX 200 tech sector's three biggest companies.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Share Gainers

Why Amaero, AMP, Block, and South32 shares are racing higher today

These shares are starting the week on a positive note. But why?

Read more »

Man with a hand on his head looks at a red stock market chart showing a falling share price.
Share Fallers

Why Brightstar, Eagers Automotive, Regis Resources, and Westpac shares are sinking

These shares are starting the week in the red. But why?

Read more »

growth charts with small cap written on a sticky note
Small Cap Shares

Expert names 3 ASX small-cap stocks to buy in July

ASX small-cap stocks have greater ability to generate outsized returns, but can be difficult to discover.

Read more »

A young couple hug each other and smile at the camera standing in front of their brand new luxury car
Share Market News

Are CAR Group shares a buy ahead of reporting season?

Will CAR Group shares take off from here?

Read more »

Worker on a laptop at an oil and gas pipeline.
Broker Notes

How much upside does Macquarie predict for Santos shares?

Let’s find out what the broker says.

Read more »

A young woman sits at her desk in deep contemplation with her hand to her chin while seriously considering information she is reading on her laptop.
Broker Notes

Does Macquarie rate REA Group shares a buy, hold or sell?

Let's have a look at what the broker thinks.

Read more »